Julie An M Talano, MD

Pediatric Hematology-Oncology, Pediatrics
Children’s Wisconsin since 1999
  • Medical Director, Blood and Marrow Transplant, Children's Wisconsin
  • Professor, Medical College of Wisconsin

Locations

Overview

Services

Children deserve the best and the most advanced medical care.  When a child is diagnosed with cancer or a disorder which requires a bone marrow transplant, our desire is to offer them the most cutting edge care with novel research initiatives. The ultimate goal is to help improve survival and lessen the side effects of transplantation.  By leading the bone marrow transplant clinical research team, Dr. Talano’s strive to bring from the bench to the bedside opportunities to each patient to help improve upon our prior results. We treat every child as if they are our own- and strive every day to make a difference.

 

Certifications

  • Pediatric Hematology-Oncology, Pediatrics

Areas of Interest

  • Aplastic anemia
  • BMT
  • BMT alternative donors
  • BMT for aplastic anemia
  • BMT for leukemia
  • BMT non myeloablative
  • BMT for sickle cell disease
  • Bone marrow failure diseases
  • Cancer
  • Clinical trials
  • Hemophagocytic lymphohistiocytosis
  • Histiocytosis
Show less... Show more...

Education and Awards

Education

  • , Georgetown University, BS
  • 1995, Northwestern University (Evanston, IL), MD

Residencies

  • 1998, Children's Memorial Hospital (Chicago, IL) - Pediatrics

Fellowships

  • 2003, Medical College of Wisconsin - Ped Hem/Onc

Awards

  • 11/2006 Best Abstract, National Marrow Donor Program Council Meeting
  • 2009 - 2013 Included in Best Doctors in America
  • 2011 Included in Super Doctors
  • Best Doctors in America

National elected/appointed leadership and committee positions

  • 2016-Present Chair, Pediatric Blood and Marrow Transplant Annual Education Meeting (PBMTC)
  • 2015-2016-Vice Chair, Pediatric Blood and Marrow Transplant Annual Education Meeting, PBMTC
  • 2015-Present Pediatric Special Interest Group (PSIG) Steering Committee, ASBMT
  • 2015-Present Program Committee, American Society of Pediatric Hematology Oncology Annual Meeting
  • 2013-Present DSMB, HPDSC Trial
  • 2013-Present Vice Chair, Non Malignant Study, Pediatric Blood and Marrow Transplant Consortium (PBMTC)
  • 2012-Present Member, Treosulfan BMT Protocol Team, Pediatric Blood and Marrow Transplant Consortium (PBMTC)
  • 2012-Present Member, Finance Committee, Pediatric Blood and Marrow Transplant Consortium (PBMTC)
  • 2011-2013-Organizing Committee, ASPHO Bone Marrow Transplant Workshop, ASPHO/PBMTC
  • 2011-Present Steering Committee Member, Multi-institutional Consortium for Haploidentical Transplantation for Patients with Sickle Cell Disease
  • 2009-Present Member, Pediatric Cancer Working Committee, Center for International Blood and Marrow Transplant Research (CIBMTR)

Editorship

  • 2012-2015-CTSI Grant Reviewer

Journal Review

  • 2006-Present Pediatric Hematology and Oncology
  • 2008-Present Pediatric Blood and Cancer
  • 2015-Present Bone Marrow Transplantation
  • 2015-Present Pediatric Transplantation

Research and publications

Research

Alternative donor blood and marrow transplantation, hemophagocytic lymphohistiocytosis, blood and marrow transplantation for leukemias, and cellular therapy.

Grants

Title: Phase 1 Multi-viral CTLs for Recipients of Grafts Rigorously Depleted of T Cells
Source: Clinical & Translational Science Institute
Role: Co-Principal Investigator
PI: Taylor, Carolyn PhD & Talano, Julie MD
Dates: 6/1/2011 - 5/31/2013
Direct Funds: $50,000

Title: Haploidentical Transplantation for patients with severe Sickle Cell Disease
Source: Busulfex
Role: Co-Principal Investigator
Dates: 1/1/2012 - 12/31/2013
Direct Funds: $25,000 (1 year)

Title: Hyundai Hope on Wheels for Pediatric Cancer Award
Source: Hyundai/Children's Wisconsin
Role: Principal Investigator
Dates: 9/1/2012 - 8/31/2015
Direct Funds: $250,000

Title: Haploidentical Transplantation for patients with severe Sickle Cell Disease
Source: FDA RO1
Role: Co-PI
Dates: 1/1/2013-12/31/2015
Direct Funds: $50,000 (3 year)

Publications